Compile Data Set for Download or QSAR
Report error Found 61 Enz. Inhib. hit(s) with all data for entry = 11825
TargetGlyceraldehyde-3-phosphate dehydrogenase(Human)
Design Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 651542BDBM651542(US20240050576, Compound 17)
Affinity DataEC50: <100nMAssay Description:Cell culture: Cells were cultured in RPMI1640 medium+15% FBS. Cells were maintained at a density between 2e5/mL and 1e6/mL. Cells were centrifuged, r...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/23/2024
Entry Details
US Patent

TargetGlyceraldehyde-3-phosphate dehydrogenase(Human)
Design Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 651543BDBM651543(US20240050576, Compound 19)
Affinity DataEC50: <100nMAssay Description:Cell culture: Cells were cultured in RPMI1640 medium+15% FBS. Cells were maintained at a density between 2e5/mL and 1e6/mL. Cells were centrifuged, r...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/23/2024
Entry Details
US Patent

TargetGlyceraldehyde-3-phosphate dehydrogenase(Human)
Design Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 651576BDBM651576(US20240050576, Compound 58)
Affinity DataEC50: <100nMAssay Description:Cell culture: Cells were cultured in RPMI1640 medium+15% FBS. Cells were maintained at a density between 2e5/mL and 1e6/mL. Cells were centrifuged, r...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/23/2024
Entry Details
US Patent

TargetGlyceraldehyde-3-phosphate dehydrogenase(Human)
Design Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 651577BDBM651577(US20240050576, Compound 59)
Affinity DataEC50: <100nMAssay Description:Cell culture: Cells were cultured in RPMI1640 medium+15% FBS. Cells were maintained at a density between 2e5/mL and 1e6/mL. Cells were centrifuged, r...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/23/2024
Entry Details
US Patent

TargetGlyceraldehyde-3-phosphate dehydrogenase(Human)
Design Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 651570BDBM651570(US20240050576, Compound 52)
Affinity DataEC50: <100nMAssay Description:Cell culture: Cells were cultured in RPMI1640 medium+15% FBS. Cells were maintained at a density between 2e5/mL and 1e6/mL. Cells were centrifuged, r...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/23/2024
Entry Details
US Patent

TargetGlyceraldehyde-3-phosphate dehydrogenase(Human)
Design Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 651540BDBM651540(US20240050576, Compound 13)
Affinity DataEC50: <100nMAssay Description:Cell culture: Cells were cultured in RPMI1640 medium+15% FBS. Cells were maintained at a density between 2e5/mL and 1e6/mL. Cells were centrifuged, r...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/23/2024
Entry Details
US Patent

TargetGlyceraldehyde-3-phosphate dehydrogenase(Human)
Design Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 651553BDBM651553(US20240050576, Compound 31)
Affinity DataEC50: <100nMAssay Description:Cell culture: Cells were cultured in RPMI1640 medium+15% FBS. Cells were maintained at a density between 2e5/mL and 1e6/mL. Cells were centrifuged, r...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/23/2024
Entry Details
US Patent

TargetGlyceraldehyde-3-phosphate dehydrogenase(Human)
Design Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 651579BDBM651579(US20240050576, Compound 62)
Affinity DataEC50: <100nMAssay Description:Cell culture: Cells were cultured in RPMI1640 medium+15% FBS. Cells were maintained at a density between 2e5/mL and 1e6/mL. Cells were centrifuged, r...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/23/2024
Entry Details
US Patent

TargetGlyceraldehyde-3-phosphate dehydrogenase(Human)
Design Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 651548BDBM651548(US20240050576, Compound 24)
Affinity DataEC50: <100nMAssay Description:Cell culture: Cells were cultured in RPMI1640 medium+15% FBS. Cells were maintained at a density between 2e5/mL and 1e6/mL. Cells were centrifuged, r...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/23/2024
Entry Details
US Patent

TargetGlyceraldehyde-3-phosphate dehydrogenase(Human)
Design Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 651580BDBM651580(US20240050576, Compound 63)
Affinity DataEC50: <100nMAssay Description:Cell culture: Cells were cultured in RPMI1640 medium+15% FBS. Cells were maintained at a density between 2e5/mL and 1e6/mL. Cells were centrifuged, r...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/23/2024
Entry Details
US Patent

TargetGlyceraldehyde-3-phosphate dehydrogenase(Human)
Design Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 651590BDBM651590(US20240050576, Compound 99)
Affinity DataEC50: <100nMAssay Description:Cell culture: Cells were cultured in RPMI1640 medium+15% FBS. Cells were maintained at a density between 2e5/mL and 1e6/mL. Cells were centrifuged, r...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/23/2024
Entry Details
US Patent

TargetGlyceraldehyde-3-phosphate dehydrogenase(Human)
Design Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 651558BDBM651558(US20240050576, Compound 39)
Affinity DataEC50: <100nMAssay Description:Cell culture: Cells were cultured in RPMI1640 medium+15% FBS. Cells were maintained at a density between 2e5/mL and 1e6/mL. Cells were centrifuged, r...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/23/2024
Entry Details
US Patent

TargetGlyceraldehyde-3-phosphate dehydrogenase(Human)
Design Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 651559BDBM651559(US20240050576, Compound 40)
Affinity DataEC50: <100nMAssay Description:Cell culture: Cells were cultured in RPMI1640 medium+15% FBS. Cells were maintained at a density between 2e5/mL and 1e6/mL. Cells were centrifuged, r...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/23/2024
Entry Details
US Patent

TargetGlyceraldehyde-3-phosphate dehydrogenase(Human)
Design Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 651593BDBM651593(US20240050576, Compound 102)
Affinity DataEC50: <100nMAssay Description:Cell culture: Cells were cultured in RPMI1640 medium+15% FBS. Cells were maintained at a density between 2e5/mL and 1e6/mL. Cells were centrifuged, r...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/23/2024
Entry Details
US Patent

TargetGlyceraldehyde-3-phosphate dehydrogenase(Human)
Design Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 651561BDBM651561(US20240050576, Compound 42)
Affinity DataEC50: <100nMAssay Description:Cell culture: Cells were cultured in RPMI1640 medium+15% FBS. Cells were maintained at a density between 2e5/mL and 1e6/mL. Cells were centrifuged, r...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/23/2024
Entry Details
US Patent

TargetGlyceraldehyde-3-phosphate dehydrogenase(Human)
Design Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 651555BDBM651555(US20240050576, Compound 35)
Affinity DataEC50: <100nMAssay Description:Cell culture: Cells were cultured in RPMI1640 medium+15% FBS. Cells were maintained at a density between 2e5/mL and 1e6/mL. Cells were centrifuged, r...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/23/2024
Entry Details
US Patent

TargetGlyceraldehyde-3-phosphate dehydrogenase(Human)
Design Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 651556BDBM651556(US20240050576, Compound 36)
Affinity DataEC50: <100nMAssay Description:Cell culture: Cells were cultured in RPMI1640 medium+15% FBS. Cells were maintained at a density between 2e5/mL and 1e6/mL. Cells were centrifuged, r...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/23/2024
Entry Details
US Patent

TargetGlyceraldehyde-3-phosphate dehydrogenase(Human)
Design Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 651557BDBM651557(US20240050576, Compound 38)
Affinity DataEC50: <100nMAssay Description:Cell culture: Cells were cultured in RPMI1640 medium+15% FBS. Cells were maintained at a density between 2e5/mL and 1e6/mL. Cells were centrifuged, r...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/23/2024
Entry Details
US Patent

TargetGlyceraldehyde-3-phosphate dehydrogenase(Human)
Design Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 651567BDBM651567(US20240050576, Compound 49)
Affinity DataEC50: <100nMAssay Description:Cell culture: Cells were cultured in RPMI1640 medium+15% FBS. Cells were maintained at a density between 2e5/mL and 1e6/mL. Cells were centrifuged, r...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/23/2024
Entry Details
US Patent

TargetGlyceraldehyde-3-phosphate dehydrogenase(Human)
Design Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 651536BDBM651536(US20240050576, Compound 8)
Affinity DataEC50: <100nMAssay Description:Cell culture: Cells were cultured in RPMI1640 medium+15% FBS. Cells were maintained at a density between 2e5/mL and 1e6/mL. Cells were centrifuged, r...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/23/2024
Entry Details
US Patent

TargetGlyceraldehyde-3-phosphate dehydrogenase(Human)
Design Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 651568BDBM651568(US20240050576, Compound 50)
Affinity DataEC50: <100nMAssay Description:Cell culture: Cells were cultured in RPMI1640 medium+15% FBS. Cells were maintained at a density between 2e5/mL and 1e6/mL. Cells were centrifuged, r...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/23/2024
Entry Details
US Patent

TargetGlyceraldehyde-3-phosphate dehydrogenase(Human)
Design Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 651569BDBM651569(US20240050576, Compound 51)
Affinity DataEC50: <100nMAssay Description:Cell culture: Cells were cultured in RPMI1640 medium+15% FBS. Cells were maintained at a density between 2e5/mL and 1e6/mL. Cells were centrifuged, r...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/23/2024
Entry Details
US Patent

TargetGlyceraldehyde-3-phosphate dehydrogenase(Human)
Design Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 651594BDBM651594(US20240050576, Compound 103)
Affinity DataEC50: <100nMAssay Description:Cell culture: Cells were cultured in RPMI1640 medium+15% FBS. Cells were maintained at a density between 2e5/mL and 1e6/mL. Cells were centrifuged, r...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/23/2024
Entry Details
US Patent

TargetGlyceraldehyde-3-phosphate dehydrogenase(Human)
Design Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 651544BDBM651544(US20240050576, Compound 20)
Affinity DataEC50:  300nMAssay Description:Cell culture: Cells were cultured in RPMI1640 medium+15% FBS. Cells were maintained at a density between 2e5/mL and 1e6/mL. Cells were centrifuged, r...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/23/2024
Entry Details
US Patent

TargetGlyceraldehyde-3-phosphate dehydrogenase(Human)
Design Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 651545BDBM651545(US20240050576, Compound 21)
Affinity DataEC50:  300nMAssay Description:Cell culture: Cells were cultured in RPMI1640 medium+15% FBS. Cells were maintained at a density between 2e5/mL and 1e6/mL. Cells were centrifuged, r...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/23/2024
Entry Details
US Patent

TargetGlyceraldehyde-3-phosphate dehydrogenase(Human)
Design Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 651538BDBM651538(US20240050576, Compound 10)
Affinity DataEC50:  300nMAssay Description:Cell culture: Cells were cultured in RPMI1640 medium+15% FBS. Cells were maintained at a density between 2e5/mL and 1e6/mL. Cells were centrifuged, r...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/23/2024
Entry Details
US Patent

TargetGlyceraldehyde-3-phosphate dehydrogenase(Human)
Design Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 651541BDBM651541(US20240050576, Compound 16)
Affinity DataEC50:  300nMAssay Description:Cell culture: Cells were cultured in RPMI1640 medium+15% FBS. Cells were maintained at a density between 2e5/mL and 1e6/mL. Cells were centrifuged, r...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/23/2024
Entry Details
US Patent

TargetGlyceraldehyde-3-phosphate dehydrogenase(Human)
Design Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 651550BDBM651550(US20240050576, Compound 26)
Affinity DataEC50:  300nMAssay Description:Cell culture: Cells were cultured in RPMI1640 medium+15% FBS. Cells were maintained at a density between 2e5/mL and 1e6/mL. Cells were centrifuged, r...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/23/2024
Entry Details
US Patent

TargetGlyceraldehyde-3-phosphate dehydrogenase(Human)
Design Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 651551BDBM651551(US20240050576, Compound 29)
Affinity DataEC50:  300nMAssay Description:Cell culture: Cells were cultured in RPMI1640 medium+15% FBS. Cells were maintained at a density between 2e5/mL and 1e6/mL. Cells were centrifuged, r...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/23/2024
Entry Details
US Patent

TargetGlyceraldehyde-3-phosphate dehydrogenase(Human)
Design Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 651546BDBM651546(US20240050576, Compound 22)
Affinity DataEC50:  300nMAssay Description:Cell culture: Cells were cultured in RPMI1640 medium+15% FBS. Cells were maintained at a density between 2e5/mL and 1e6/mL. Cells were centrifuged, r...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/23/2024
Entry Details
US Patent

TargetGlyceraldehyde-3-phosphate dehydrogenase(Human)
Design Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 651547BDBM651547(US20240050576, Compound 23)
Affinity DataEC50:  300nMAssay Description:Cell culture: Cells were cultured in RPMI1640 medium+15% FBS. Cells were maintained at a density between 2e5/mL and 1e6/mL. Cells were centrifuged, r...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/23/2024
Entry Details
US Patent

TargetGlyceraldehyde-3-phosphate dehydrogenase(Human)
Design Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 651549BDBM651549(US20240050576, Compound 25)
Affinity DataEC50:  300nMAssay Description:Cell culture: Cells were cultured in RPMI1640 medium+15% FBS. Cells were maintained at a density between 2e5/mL and 1e6/mL. Cells were centrifuged, r...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/23/2024
Entry Details
US Patent

TargetGlyceraldehyde-3-phosphate dehydrogenase(Human)
Design Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 651591BDBM651591(US20240050576, Compound 100)
Affinity DataEC50:  300nMAssay Description:Cell culture: Cells were cultured in RPMI1640 medium+15% FBS. Cells were maintained at a density between 2e5/mL and 1e6/mL. Cells were centrifuged, r...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/23/2024
Entry Details
US Patent

TargetGlyceraldehyde-3-phosphate dehydrogenase(Human)
Design Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 651592BDBM651592(US20240050576, Compound 101)
Affinity DataEC50:  300nMAssay Description:Cell culture: Cells were cultured in RPMI1640 medium+15% FBS. Cells were maintained at a density between 2e5/mL and 1e6/mL. Cells were centrifuged, r...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/23/2024
Entry Details
US Patent

TargetGlyceraldehyde-3-phosphate dehydrogenase(Human)
Design Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 651586BDBM651586(US20240050576, Compound 87)
Affinity DataEC50:  300nMAssay Description:Cell culture: Cells were cultured in RPMI1640 medium+15% FBS. Cells were maintained at a density between 2e5/mL and 1e6/mL. Cells were centrifuged, r...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/23/2024
Entry Details
US Patent

TargetGlyceraldehyde-3-phosphate dehydrogenase(Human)
Design Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 651589BDBM651589(US20240050576, Compound 90)
Affinity DataEC50:  300nMAssay Description:Cell culture: Cells were cultured in RPMI1640 medium+15% FBS. Cells were maintained at a density between 2e5/mL and 1e6/mL. Cells were centrifuged, r...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/23/2024
Entry Details
US Patent

TargetGlyceraldehyde-3-phosphate dehydrogenase(Human)
Design Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 651534BDBM651534(US20240050576, Compound 3)
Affinity DataEC50:  300nMAssay Description:Cell culture: Cells were cultured in RPMI1640 medium+15% FBS. Cells were maintained at a density between 2e5/mL and 1e6/mL. Cells were centrifuged, r...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/23/2024
Entry Details
US Patent

TargetGlyceraldehyde-3-phosphate dehydrogenase(Human)
Design Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 651535BDBM651535(US20240050576, Compound 6)
Affinity DataEC50:  300nMAssay Description:Cell culture: Cells were cultured in RPMI1640 medium+15% FBS. Cells were maintained at a density between 2e5/mL and 1e6/mL. Cells were centrifuged, r...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/23/2024
Entry Details
US Patent

TargetGlyceraldehyde-3-phosphate dehydrogenase(Human)
Design Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 651537BDBM651537(US20240050576, Compound 9)
Affinity DataEC50:  300nMAssay Description:Cell culture: Cells were cultured in RPMI1640 medium+15% FBS. Cells were maintained at a density between 2e5/mL and 1e6/mL. Cells were centrifuged, r...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/23/2024
Entry Details
US Patent

TargetGlyceraldehyde-3-phosphate dehydrogenase(Human)
Design Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 651574BDBM651574(US20240050576, Compound 56)
Affinity DataEC50:  300nMAssay Description:Cell culture: Cells were cultured in RPMI1640 medium+15% FBS. Cells were maintained at a density between 2e5/mL and 1e6/mL. Cells were centrifuged, r...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/23/2024
Entry Details
US Patent

TargetGlyceraldehyde-3-phosphate dehydrogenase(Human)
Design Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 651575BDBM651575(US20240050576, Compound 57)
Affinity DataEC50:  300nMAssay Description:Cell culture: Cells were cultured in RPMI1640 medium+15% FBS. Cells were maintained at a density between 2e5/mL and 1e6/mL. Cells were centrifuged, r...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/23/2024
Entry Details
US Patent

TargetGlyceraldehyde-3-phosphate dehydrogenase(Human)
Design Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 651571BDBM651571(US20240050576, Compound 53)
Affinity DataEC50:  300nMAssay Description:Cell culture: Cells were cultured in RPMI1640 medium+15% FBS. Cells were maintained at a density between 2e5/mL and 1e6/mL. Cells were centrifuged, r...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/23/2024
Entry Details
US Patent

TargetGlyceraldehyde-3-phosphate dehydrogenase(Human)
Design Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 651572BDBM651572(US20240050576, Compound 54)
Affinity DataEC50:  300nMAssay Description:Cell culture: Cells were cultured in RPMI1640 medium+15% FBS. Cells were maintained at a density between 2e5/mL and 1e6/mL. Cells were centrifuged, r...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/23/2024
Entry Details
US Patent

TargetGlyceraldehyde-3-phosphate dehydrogenase(Human)
Design Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 651573BDBM651573(US20240050576, Compound 55)
Affinity DataEC50:  300nMAssay Description:Cell culture: Cells were cultured in RPMI1640 medium+15% FBS. Cells were maintained at a density between 2e5/mL and 1e6/mL. Cells were centrifuged, r...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/23/2024
Entry Details
US Patent

TargetGlyceraldehyde-3-phosphate dehydrogenase(Human)
Design Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 651578BDBM651578(US20240050576, Compound 60)
Affinity DataEC50:  300nMAssay Description:Cell culture: Cells were cultured in RPMI1640 medium+15% FBS. Cells were maintained at a density between 2e5/mL and 1e6/mL. Cells were centrifuged, r...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/23/2024
Entry Details
US Patent

TargetGlyceraldehyde-3-phosphate dehydrogenase(Human)
Design Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 651581BDBM651581(US20240050576, Compound 65)
Affinity DataEC50:  300nMAssay Description:Cell culture: Cells were cultured in RPMI1640 medium+15% FBS. Cells were maintained at a density between 2e5/mL and 1e6/mL. Cells were centrifuged, r...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/23/2024
Entry Details
US Patent

TargetGlyceraldehyde-3-phosphate dehydrogenase(Human)
Design Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 651560BDBM651560(US20240050576, Compound 41)
Affinity DataEC50:  300nMAssay Description:Cell culture: Cells were cultured in RPMI1640 medium+15% FBS. Cells were maintained at a density between 2e5/mL and 1e6/mL. Cells were centrifuged, r...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/23/2024
Entry Details
US Patent

TargetGlyceraldehyde-3-phosphate dehydrogenase(Human)
Design Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 651554BDBM651554(US20240050576, Compound 33)
Affinity DataEC50:  300nMAssay Description:Cell culture: Cells were cultured in RPMI1640 medium+15% FBS. Cells were maintained at a density between 2e5/mL and 1e6/mL. Cells were centrifuged, r...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/23/2024
Entry Details
US Patent

TargetGlyceraldehyde-3-phosphate dehydrogenase(Human)
Design Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 651563BDBM651563(US20240050576, Compound 44)
Affinity DataEC50:  300nMAssay Description:Cell culture: Cells were cultured in RPMI1640 medium+15% FBS. Cells were maintained at a density between 2e5/mL and 1e6/mL. Cells were centrifuged, r...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/23/2024
Entry Details
US Patent

TargetGlyceraldehyde-3-phosphate dehydrogenase(Human)
Design Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 651564BDBM651564(US20240050576, Compound 45)
Affinity DataEC50:  300nMAssay Description:Cell culture: Cells were cultured in RPMI1640 medium+15% FBS. Cells were maintained at a density between 2e5/mL and 1e6/mL. Cells were centrifuged, r...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/23/2024
Entry Details
US Patent

Displayed 1 to 50 (of 61 total ) | Next | Last >>
Jump to: